Manufacturer record

Kaalinga Health Care: regulatory record

Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

4 batches manufactured by Kaalinga Health Care (Himachal Pradesh) were declared Not of Standard Quality between July 2025 and September 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Most recent flagged batch: 26KHT-0255, Pantoprazole Sodium Gastro-resistant Tablets IP' (exp Jan 2028). DTL, Thrissur (state lab) found it not of standard quality: The Sample does not conform to the IP standards with respect to the tests Dissolution and Assay. Listed in the September 2026 alert.

Records by type

4 records linked to Kaalinga Health Care in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
4Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Jul 2025 to Sep 2026

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

4
NSQ batches since 2025
4
Products affected
Assay
Most common failure
Sep 2026
Latest alert

Flagged batches per year

2025 · 32026 · 1

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Pantoprazole Sodium Gastro-resistant Tablets IP' Batch 26KHT-0255Mfg Feb 2026 · Exp Jan 2028 The Sample does not conform to the IP standards with respect to the tests Dissolution and Assay.Assay DTL, ThrissurState lab Sep 2026
Amoxycillin, Potassium Clavulanate & Lactic Acid Bacillus Tablets Batch 24KHBT-0194Mfg Oct 2024 · Exp Mar 2026 The content of Clavulanic Acid in the sample is less (i.e. 26.94% of the labelled amount than the Schedule V Limit. Schedule V Limit 90% to 130% of Labelled AmountLabelling FDA, Lab, M.S Chhatrapati Sambhaji Nagar Maharashtra StateState lab Nov 2025
ZORACEF ? 500 (Cefuroxime Axetil Tablets I.P) Batch 25KHCT-0031Mfg Jan 2025 · Exp Dec 2026 The sample does not conform to standard quality in respect of the test for ?Dissolution? performed.Dissolution State Drugs Testing Laboratory, Agartala, TripuraState lab Jul 2025
Migranap - D Batch KHT- 0689Mfg Sep 2023 · Exp Aug 2025 Failing in AssayAssay Drug Testing Laboratory Dalgate, Jammu and KashmirState lab Jul 2025

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.